BioLineRx Ltd. (ADR)

General ticker "BLRX" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $260.2M (TTM average)

BioLineRx Ltd. (ADR) follows the US Stock Market performance with the rate: 9.8%.

Estimated limits based on current volatility of 3.2%: low 2.78$, high 2.97$

Factors to consider:

  • Total employees count: 52 as of 2011
  • Current price 43.1% below estimated low
  • Earnings for 6 months up through Q2 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [6.38$, 21.47$]
  • 2025-12-31 to 2026-12-31 estimated range: [5.10$, 17.10$]

Financial Metrics affecting the BLRX estimates:

  • Positive: with PPE of 2.4 at the end of fiscal year the price was low
  • Negative: Operating cash flow per share per price, % of -6.41 <= 0.06
  • Negative: negative Operating income
  • Negative: negative Net income
  • Positive: 19.59 < Shareholder equity ratio, % of 34.60 <= 42.74
  • Negative: negative Industry operating cash flow (median)
  • Positive: Investing cash flow per share per price, % of 4.29 > -0.64
  • Negative: 0.73 < Interest expense per share per price, % of 1.34

Similar symbols

Short-term BLRX quotes

Long-term BLRX plot with estimates

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $0.00MM $4.80MM $28.94MM
Operating Expenses $29.16MM $54.49MM $49.35MM
Operating Income $-29.16MM $-49.69MM $-20.41MM
Non-Operating Income $4.21MM $-10.92MM $11.19MM
Interest Expense $2.16MM $2.17MM $9.16MM
R&D Expense $17.63MM $12.52MM $9.15MM
Income(Loss) $-24.95MM $-60.61MM $-9.22MM
Profit(Loss)* $-24.95MM $-60.61MM $-9.22MM
Stockholders Equity $50.84MM $13.22MM $13.46MM
Inventory $0.20MM $1.95MM $3.15MM
Assets $76.38MM $63.92MM $38.91MM
Operating Cash Flow $-26.24MM $-22.61MM $-43.87MM
Capital expenditure $0.32MM $0.30MM $0.05MM
Investing Cash Flow $4.01MM $1.44MM $29.37MM
Financing Cash Flow $20.44MM $15.06MM $20.66MM
Earnings Per Share** $-0.48 $-0.94 $-0.12
Ordinary share to ADR 1.00x 1.00x 1.00x

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.